Camber Capital Management LP Ascendis Pharma A/S Transaction History
Camber Capital Management LP
- $4.32 Billion
- Q4 2024
A detailed history of Camber Capital Management LP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Camber Capital Management LP holds 800,000 shares of ASND stock, worth $132 Million. This represents 2.55% of its overall portfolio holdings.
Number of Shares
800,000
Previous 700,000
14.29%
Holding current value
$132 Million
Previous $105 Million
5.38%
% of portfolio
2.55%
Previous 3.32%
Shares
9 transactions
Others Institutions Holding ASND
# of Institutions
235Shares Held
59.5MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.67 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$912 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$842 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$735 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$723 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.21B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...